VivoSeq
Other

Intraocular Pressure

0

Pipeline Programs↗

5

Active Trials↗

11

Companies Involved↗

Intraocular Pressure is an early-stage landscape with 0 programs across 11 companies. The most active players are Aerie Pharmaceuticals, AbbVie, Astellas.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Aerie Pharmaceuticals

0 programs

PreclinicalAbbVie logo

AbbVie

0 programs

PreclinicalAstellas logo

Astellas

0 programs

PreclinicalC

Can-Fite BioPharma

0 programs

PreclinicalA

Alleanza Pharmaceuticals, Inc.

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

90

clinical trials

Completed69 · 77%
Unknown status11 · 12%
Terminated4 · 4%
Active, not recruiting2 · 2%
Recruiting2 · 2%
Withdrawn1 · 1%
Other1 · 1%

Clinical Trials

Trial Activity

90 trials

Effects of Dexmedetomidine on Intraocular Pressure During Scheduled Spine Surgeries
Recruiting·—·N/A·NCT04628663·60 enrolled
Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients
Recruiting·UUniversity of Florida·Phase 4·NCT04281017·40 enrolled
Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction
Active, not recruiting·AAlcon Research·Phase 3·NCT07082816·489 enrolled
Use of Methazolamide to Lower Intraocular Pressure
Active, not recruiting·UUniversity of Colorado, Denver·Phase 4·NCT05498103·30 enrolled
Propofol Versus Sevoflurane Anesthesia on the Intraocular Pressure and Hemodynamics in Patient Undergoing Cyclophotocoagulation
Not yet recruiting·SSohag University·N/A·NCT07445672·40 enrolled
Efficacy of Latanoprostene Bunod in Lowering Intraocular Pressure in Japanese Healthy Male Volunteers
Completed·BBausch & Lomb Incorporated·Phase 1·NCT01895985·24 enrolled
A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects
Completed·Astellas logoAstellas·Phase 1·NCT01284309·321 enrolled
Interval Intraocular Pressure in Intravitreal Injection Study
Completed·TThe University of Hong Kong·N/A·NCT04868175·64 enrolled
Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions
Completed·UUniversity of Michigan·Phase 4·NCT00906087·14 enrolled
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
Completed·UUniversity of Colorado, Denver·N/A·NCT02754570·27 enrolled
Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure
Completed·AAerie Pharmaceuticals·Phase 2·NCT01060579·217 enrolled
To Assess the Safety and Efficacy of Travacom in Patients With Uncontrolled Intraocular Pressure
Completed·AAlcon Research·Phase 4·NCT01159756·468 enrolled
A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin
Completed·AAlcon Research·Phase 4·NCT00759941·86 enrolled
Effects of Intravenous Clonidine on Ocular Blood Flow and Intraocular Pressure
Completed·MMedical University of Vienna·Phase 4·NCT00279253·12 enrolled
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Completed·AAerie Pharmaceuticals·Phase 2·NCT01699464·211 enrolled
Page 1 of 6

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)